Inflamm-ageing

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 16, Issue 1, 2013, Pages 14-20

  Cevenini, Elisa ^a   Monti, Daniela ^b   Franceschi, Claudio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

cellular senescence; gut microbiota; inflamm ageing; metaflammation; nutrition

Indexed keywords

I KAPPA B; INTERLEUKIN 6; INTERLEUKIN 8;

AGING; CANCER GROWTH; CANCER INHIBITION; CELL AGING; CELL FUNCTION; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ELDERLY CARE; HEALTH STATUS; HUMAN; INFLAMM AGEING; INFLAMMATION; INTESTINE FLORA; INTESTINE LYMPHATIC TISSUE; LIFESPAN; METAFLAMMATION; NUTRITIONAL STATUS; ONSET AGE; PATHOGENESIS; PROTEIN EXPRESSION; REVIEW; TISSUE REPAIR; TRANSCRIPTION REGULATION; TREATMENT INDICATION;

AGED; AGING; CELL AGING; GASTROINTESTINAL TRACT; HEALTH STATUS; HUMANS; INFLAMMATION; METAGENOME; NF-KAPPA B;

EID: 84871925936     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32835ada13     Document Type: Review

References (43)

1. Franceschi C, Bonafe M, Valensin S, et al. Inflamm-aging: an evolutionaryperspective on immunosenescence. Ann N Y Acad Sci 2000; 908:244-254
2. De Martinis M, Franceschi C, Monti D, Ginaldi L. Inflamm-aging and lifelongantigenic load as major determinants of aging rate and longevity. FEBS Lett2005; 579:2035-2039 (Pubitemid 40469666)
3. Bucci L, Ostan R, Capri S, et al. Inflamm-aging: handbook on immunosenesce-basic understanding and clinical applications. 1. In: Fulop T, Franceschi C,Hirokawa K and Pawelec G, editors. The Netherlands: Springer Science\+BusinessMedia B.V; 2009. pp. 893-918
4. Franceschi C, Capri M, Monti D, et al. Inflamm-aging and antiinflamm-aging: asystemic perspective on aging and longevity emerged from studies in humans.Mech Aging Dev 2007; 128:92-105 (Pubitemid 46073065)
5. Franceschi C, Bonafe M. Centenarians as a model for healthy aging. BiochemSoc Trans 2003; 31:457-461 (Pubitemid 36520700)
6. Cevenini E, Invidia L, Lescai F, et al. Human models of aging and longevity.Expert Opin Biol Ther 2008; 8:1393-1405
7. Cevenini E, Bellavista E, Tieri P, et al. Systems biology and longevity: anemerging approach to identify innovative antiaging targets and strategies.Curr Pharm Des 2010; 16:802-813
8. Salminen A, Huuskonen J, Ojala J, et al. Activation of innate immunity systemduring aging: NF-kB signaling is the molecular culprit of inflamm-aging. AgingRes Rev 2008; 7:83-105 (Pubitemid 351418294)
9. Tieri P, Termanini A, Bellavista E, et al. Charting the NF-kB pathway interactomemap. PLoS One 2012; 7:e32678
10. Rodier F, Campisi J. Four faces of cellular senescence. J Cell Biol 2011;192:547-556
11. Di Leonardo A, Linke SP, Clarkin K, Wahl GM. DNA damage triggers aprolonged p53-dependent G1 arrest and long-term induction of Cip1 innormal human fibroblasts. Genes Dev 1994; 8:2540-2551 (Pubitemid 24347245)
12. Rodier F, Coppé JP, Patil CK, et al. Persistent DNA damage signalling triggerssenescence-associated inflammatory cytokine secretion. Nat Cell Biol 2009;11:973-979
13. Rodier F, Muñ oz DP, Teachenor R, et al. DNA-SCARS: distinct nuclearstructures that sustain damage-induced senescence growth arrest andinflammatory cytokine secretion. J Cell Sci 2011; 124:68-81
14. Orjalo AV, Bhaumik D, Gengler BK, et al. Cell surface-bound IL-1a is anupstream regulator of the senescence-associated IL-6/IL-8 cytokine network.Proc Natl Acad Sci USA 2009; 106:17031-17036
15. Acosta JC, O'Loghlen A, Banito A, et al. Chemokine signaling via the CXCR2receptor reinforces senescence. Cell 2008; 133:1006-1018 (Pubitemid 351795610)
16. Kuilman T, Michaloglou C, Vredeveld LCW, et al. Oncogene induced senescencerelayed by an interleukin-dependent inflammatory network. Cell 2008;133:1019-1031 (Pubitemid 351787746)
17. Freund A, Orjalo AV, Desprez PY, Campisi J. Inflammatory networks duringcellular senescence: causes and consequences. Trends Mol Med 2010;16:238-246
18. Bhaumik D, Scott GK, Schokrpur S, et al. MicroRNAs miR-146a/b negativelymodulate the senescence-associated inflammatory mediators IL-6 and IL-8.Aging 2009; 1:402-411
19. Olivieri F, Lazzarini R, Recchioni R, et al. MiR-146a as marker of senescenceassociatedpro-inflammatory status in cells involved in vascular remodelling.Age (Dordr) 2012; [Epub ahead of print] PubMed PMID:22692818
20. Taganov KD, Boldin MP. Chang KJ, and Baltimore D. NF-kappaB dependentinduction of microRNA miR-146, an inhibitor targeted to signaling proteins ofinnate immune responses. Proc Natl Acad Sci USA 2006; 103:12481-12486 (Pubitemid 44267285)
21. Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad thingshappen to good cells. Nat Rev Mol Cell Biol 2007; 8:729-740 (Pubitemid 47312822)
22. Price JS, Waters JG, Darrah C, et al. The role of chondrocyte senescence inosteoarthritis. Aging Cell 2002; 1:57-65
23. Vasile E, Tomita Y, Brown LF, et al. Differential expression of thymosin beta-10by early passage and senescent vascular endothelium is modulated byVPF/VEGF: evidence for senescent endothelial cells in vivo at sites ofatherosclerosis. FASEB J 2001; 15:458-466 (Pubitemid 32141437)
24. Cristofalo VJ. SA beta Gal staining: biomarker or delusion. Exp Gerontol2005; 40:836-838 (Pubitemid 41416547)
25. Korkaya H, Liu S, Wicha MS. Regulation of cancer stem cells by cytokinenetworks: attacking cancer's inflammatory roots. Clin Cancer Res 2011;17:6125-6129
26. Jones SA, Scheller J, Rose-John S. Therapeutic strategies for the clinicalblockade of IL-6/gp130 signaling. J Clin Invest 2011; 121:3375-3383
27. Bonafè M, Storci G, Franceschi C. Inflamm-aging of the stem cell niche:Breast cancer as a paradigmatic example: Breakdown of the multishellcytokine network fuels cancer in aged people. Bioessays 2011; 34:40-49
28. Das UN. Metabolic syndrome X: an inflammatory condition? Curr HypertensRep 2004; 6:66-73 (Pubitemid 39359545)
29. Gregor MF, Hotamisligil GkS. Inflammatory mechanisms in obesity. Ann RevImmunol 2011; 29:415-445
30. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. NatRev Immunol 2011; 11:98-107
31. Franceschi C, Garagnani P, Santoro A, et al. Healthy ageing, inflammation andnutrition. Eur J Nutr, unpublished data
32. Cevenini E, Caruso C, Candore G, et al. Age-related inflammation: thecontribution of different organs, tissues and systems. How to face it fortherapeutic approaches. Curr Pharm Des 2010; 16:609-618
33. Ottaviani E, Ventura N, Mandrioli M, et al. Gut microbiota as a candidate forlifespan extension: an ecological/evolutionary perspective targeted on livingorganisms as metaorganisms. Biogerontology 2011; 12:599-609
34. Claesson MJ, Jeffery IB, Conde S, et al. Gut microbiota composition correlateswith diet and health in the elderly. Nature 2012; 488:178-184
35. Noverr MC, Huffnagle GB. Does the microbiota regulate immune responsesoutside the gut? Trends Microbiol 2004; 12:562-568 (Pubitemid 39469905)
36. Biagi E, Nylund L, Candela M, et al. Through aging, and beyond: gutmicrobiota and inflammatory status in seniors and centenarians. PLoS One2010; 5:e10667. Erratum in: PLoS One. 2010;5(6). doi: 10.1371/annotation/df45912f- d15c-44ab-8312-e7ec0607604d
37. Biagi E, Candela M, Fairweather-Tait S, et al. Aging of the human metaorganism:the microbial counterpart. Age 2012; 34:247-267
38. Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology2009; 136:65-80
39. Candela M, Guidotti M, Fabbri A, et al. Human intestinal microbiota: crosstalkwith the host and its potential role in colorectal cancer. Crit Rev Microbiol2011; 37:1-14
40. Lovat LB. Age related changes in gut physiology and nutritional status. Gut1996; 38:306-309 (Pubitemid 26074310)
41. Franceschi C. Inflamm-aging as a major characteristic of old people: can it beprevented or cured? Nutr Rev 2007; 65:S173-176
42. Vrieze A, van Nood E, Holleman F, et al. Transfer of intestinal microbiota fromlean donors increases insulin sensitivity in individuals with metabolic syndrome.Gastroenterology 2012; 143:913-916
43. Kootte RS, Vrieze A, Holleman F, et al. The therapeutic potential of manipulatinggut microbiota in obesity and type 2 diabetes mellitus. Diabetes ObesMetab 2012; 14:112-120